Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.950
-0.200 (-3.88%)
Dec 23, 2024, 4:00 PM EST - Market closed
Exagen Employees
As of December 31, 2023, Exagen had 179 total employees, including 174 full-time and 5 part-time employees. The number of employees decreased by 25 or -12.25% compared to the previous year.
Employees
179
Change (1Y)
-25
Growth (1Y)
-12.25%
Revenue / Employee
$311,458
Profits / Employee
-$94,564
Market Cap
87.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Harvard Bioscience | 416 |
Veru Inc. | 189 |
Adagene | 174 |
Century Therapeutics | 165 |
OptimizeRx | 136 |
HilleVax | 90 |
Immunic | 77 |
Zentek | 24 |
XGN News
- 11 days ago - Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD - GlobeNewsWire
- 5 weeks ago - Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform - GlobeNewsWire
- 5 weeks ago - Exagen, Inc. (XGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence - GlobeNewsWire
- 3 months ago - Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 5 months ago - Exagen, Inc. (XGN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference - GlobeNewsWire
- 5 months ago - Exagen Appoints Jeffrey G. Black as New Chief Financial Officer - GlobeNewsWire